1. Menees S, Chey WD. Fecal incontinence: pathogenesis, diagnosis, and updated
treatment strategies. Gastroenterol Clin North Am. 2022; 51(1):71–91. DOI:
10.1016/j.gtc.2021.10.005. PMID:
35135666.
2. Ditah I, Devaki P, Luma HN, Ditah C, Njei B, Jaiyeoba C, et al. Prevalence, trends, and risk factors for fecal incontinence in
United States adults, 2005–2010. Clin Gastroenterol Hepatol. 2014; 12(4):636–643. DOI:
10.1016/j.cgh.2013.07.020. PMID:
23906873.
4. Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, et al. Fecal incontinence in US adults: epidemiology and risk
factors. Gastroenterology. 2009; 137(2):512–517. DOI:
10.1053/j.gastro.2009.04.054. PMID:
19410574. PMCID:
PMC2748224.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Piozzi GN, Kim SH. Robotic intersphincteric resection for low rectal cancer:
technical controversies and a systematic review on the perioperative,
oncological, and functional outcomes. Ann Coloproctol. 2021; 37(6):351–367. DOI:
10.3393/ac.2021.00836.0119. PMID:
34784706. PMCID:
PMC8717069.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Eldamshety O, Kotb S, Khater A, Roshdy S, Elnahas W, Zahi MS, et al. Early and late functional outcomes of anal sphincter-sparing
procedures with total mesorectal excision for anorectal
adenocarcinoma. Ann Coloproctol. 2020; 36(3):148–154. DOI:
10.3393/ac.2018.07.19. PMID:
32311866. PMCID:
PMC7392569.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Muñoz-Duyos A, Lagares-Tena L, Ribas Y, Baanante JC, Navarro-Luna A. Critical appraisal of international guidelines for the management
of fecal incontinence in adults: is it possible to define what to do in
different clinical scenarios? Tech Coloproctol. 2022; 26(1):1–17. DOI:
10.1007/s10151-021-02544-2. PMID:
34767095. PMCID:
PMC8587500.
![crossref](/image/icon/bnr_ref_cross.gif)
9. De Ligny WR, Kerkhof MH, Ruiz-Zapata AM. Regenerative medicine as a therapeutic option for fecal
incontinence: a systematic review of preclinical and clinical
studies. Am J Obstet Gynecol. 2019; 220(2):142–154. DOI:
10.1016/j.ajog.2018.09.009. PMID:
30267651.
11. Simren M, Palsson OS, Whitehead WE. Update on Rome IV criteria for colorectal disorders: implications
for clinical practice. Curr Gastroenterol Rep. 2017; 19(4):15. DOI:
10.1007/s11894-017-0554-0. PMID:
28374308. PMCID:
PMC5378729.
12. Whitehead WE, Simren M, Busby-Whitehead J, Heymen S, van Tilburg MAL, Sperber AD, et al. Fecal incontinence diagnosed by the Rome IV criteria in the
United States, Canada, and the United Kingdom. Clin Gastroenterol Hepatol. 2020; 18(2):385–391. DOI:
10.1016/j.cgh.2019.05.040. PMID:
31154029.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Pinsk I, Czeiger D, Lichtman D, Reshef A. The long-term effect of standardized anal dilatation for chronic
anal fissure on anal continence. Ann Coloproctol. 2021; 37(2):115–119. DOI:
10.3393/ac.2020.03.16. PMID:
32178506. PMCID:
PMC8134927.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Egal A, Etienney I, Atienza P. Endorectal advancement flap with muscular plication in anovaginal
and anterior perineal fistulas. Ann Coloproctol. 2021; 37(3):141–145. DOI:
10.3393/ac.2020.04.10.1. PMID:
32674556. PMCID:
PMC8273710.
19. Lee KH, Hyun K, Yoon SG, Lee JK. Minimal lateral internal sphincterotomy (LIS): is it enough to
cut less than the conventional tailored LIS? Ann Coloproctol. 2021; 37(5):275–280. DOI:
10.3393/ac.2020.00976.0139. PMID:
34246204. PMCID:
PMC8566144.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Lopez MPJ, Onglao MAS, Monroy Iii HJ. Initial experience with video-assisted anal fistula treatment in
the Philippines. Ann Coloproctol. 2020; 36(2):112–118. DOI:
10.3393/ac.2020.02.28. PMID:
32178505. PMCID:
PMC7299567.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Wallenhorst T, Bouguen G, Brochard C, Cunin D, Desfourneaux V, Ropert A, et al. Long-term impact of full-thickness rectal prolapse treatment on
fecal incontinence. Surgery. 2015; 158(1):104–111. DOI:
10.1016/j.surg.2015.03.005. PMID:
25869649.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Markland AD, Dunivan GC, Vaughan CP, Rogers RG. Anal intercourse and fecal incontinence: evidence from the
2009–2010 national health and nutrition examination
survey. Am J Gastroenterol. 2016; 111(2):269–274. DOI:
10.1038/ajg.2015.419. PMID:
26753893. PMCID:
PMC5231615.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Shin GH, Toto EL, Schey R. Pregnancy and postpartum bowel changes: constipation and fecal
incontinence. Am J Gastroenterol. 2015; 110(4):521–529. DOI:
10.1038/ajg.2015.76. PMID:
25803402.
![crossref](/image/icon/bnr_ref_cross.gif)
24. Ternent CA, Fleming F, Welton ML, Buie WD, Steele S, Rafferty J. Clinical practice guideline for ambulatory anorectal
surgery. Dis Colon Rectum. 2015; 58(10):915–922. DOI:
10.1097/DCR.0000000000000451. PMID:
26347962.
25. Paquette IM, Varma MG, Kaiser AM, Steele SR, Rafferty JF. The American Society of Colon and Rectal Surgeons’
clinical practice guideline for the treatment of fecal
incontinence. Dis Colon Rectum. 2015; 58(7):623–636. DOI:
10.1097/DCR.0000000000000397. PMID:
26200676.
![crossref](/image/icon/bnr_ref_cross.gif)
26. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit
time. Scand J Gastroenterol. 1997; 32(9):920–924. DOI:
10.3109/00365529709011203. PMID:
9299672.
27. Jorge MJN, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993; 36(1):77–97. DOI:
10.1007/BF02050307. PMID:
8416784.
![crossref](/image/icon/bnr_ref_cross.gif)
28. Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading
systems. Gut. 1999; 44(1):77–80. DOI:
10.1136/gut.44.1.77. PMID:
9862829. PMCID:
PMC1760067.
![crossref](/image/icon/bnr_ref_cross.gif)
29. Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, et al. Fecal incontinence quality of life scale: quality of life
instrument for patients with fecal incontinence. Dis Colon Rectum. 2000; 43(1):9–16. DOI:
10.1007/BF02237236. PMID:
10813117.
30. Alavi K, Chan S, Wise P, Kaiser AM, Sudan R, Bordeianou L. Fecal incontinence: etiology, diagnosis, and
management. J Gastrointest Surg. 2015; 19(10):1910–1921. DOI:
10.1007/s11605-015-2905-1. PMID:
26268955.
![crossref](/image/icon/bnr_ref_cross.gif)
31. Jeong HY, Yang SJ, Cho DH, Park DH, Lee JK. Comparison of 3-dimensional pelvic floor ultrasonography and
defecography for assessment of posterior pelvic floor
disorders. Ann Coloproctol. 2020; 36(4):256–263. DOI:
10.3393/ac.2020.02.09. PMID:
32178497. PMCID:
PMC7508475.
![crossref](/image/icon/bnr_ref_cross.gif)
32. Yune Y, Jeong HY, Park DH, Lee JK. Three-dimensional pelvic floor ultrasound assessment of pelvic
organ prolapse: minimal levator hiatus and levator ani deficiency
score. Ann Coloproctol. 2021; 37(5):291–297. DOI:
10.3393/ac.2020.01095.0156. PMID:
34376023. PMCID:
PMC8566146.
![crossref](/image/icon/bnr_ref_cross.gif)
33. Fitzpatrick M, O’brien C, O’connell PR, O’herlihy C. Patterns of abnormal pudendal nerve function that are associated
with postpartum fecal incontinence. Am J Obstet Gynecol. 2003; 189(3):730–735. DOI:
10.1067/S0002-9378(03)00817-2.
![crossref](/image/icon/bnr_ref_cross.gif)
34. Meyer I, Richter HE. Accidental bowel leakage/fecal incontinence: evidence-based
management. Obstet Gynecol Clin North Am. 2021; 48(3):467–485. DOI:
10.1016/j.ogc.2021.05.003. PMID:
34416932.
35. Norton C, Cody JD. Biofeedback and/or sphincter exercises for the treatment of
faecal incontinence in adults. Cochrane Database Syst Rev. 2012; 11(7):CD002111. DOI:
10.1002/14651858.CD002111.pub3. PMID:
22786479.
36. Eric Jelovsek J, Markland AD, Whitehead WE, Barber MD, Newman DK, Rogers RG, et al. Controlling faecal incontinence in women by performing anal
exercises with biofeedback or loperamide: a randomised clinical
trial. Lancet Gastroenterol Hepatol. 2019; 4(9):698–710. DOI:
10.1016/S2468-1253(19)30193-1.
37. Tjandra JJ, Dykes SL, Kumar RR, Ellis CN, Gregorcyk SG, Hyman NH, et al. Practice parameters for the treatment of fecal
incontinence. Dis Colon Rectum. 2007; 50(10):1497–1507. DOI:
10.1007/s10350-007-9001-x. PMID:
17674106.
38. Katuwal B, Bhullar J. Current position of sacral neuromodulation in treatment of fecal
incontinence. Clin Colon Rectal Surg. 2021; 34(1):22–27. DOI:
10.1055/s-0040-1714247. PMID:
33536846. PMCID:
PMC7843948.
39. De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel KE, et al. New technologies and applications in sacral neuromodulation: an
update. Adv Ther. 2020; 37:637–643. DOI:
10.1007/s12325-019-01205-z. PMID:
31875299. PMCID:
PMC7004424.
![crossref](/image/icon/bnr_ref_cross.gif)
40. Thaha MA, Abukar AA, Thin NN, Ramsanahie A, Knowles CH. Sacral nerve stimulation for faecal incontinence and constipation
in adults. Cochrane Database Syst Rev. 2015; (8):CD004464. DOI:
10.1002/14651858.CD004464.pub3. PMID:
26299888. PMCID:
PMC9208727.
41. Knowles CH, Horrocks EJ, Bremner SA, Stevens N, Norton C, O’Connell PR, et al. Percutaneous tibial nerve stimulation versus sham electrical
stimulation for the treatment of faecal incontinence in adults (CONFIDeNT):
a double-blind, multicentre, pragmatic, parallel-group, randomised
controlled trial. Lancet. 2015; 386(10004):1640–1648. DOI:
10.1016/S0140-6736(15)60314-2.
![crossref](/image/icon/bnr_ref_cross.gif)
42. Lukacz ES, Segall MM, Wexner SD. Evaluation of an anal insert device for the conservative
management of fecal incontinence. Dis Colon Rectum. 2015; 58(9):892–898. DOI:
10.1097/DCR.0000000000000427. PMID:
26252852.
![crossref](/image/icon/bnr_ref_cross.gif)
43. Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal
incontinence in adults. Cochrane Database Syst Rev. 2013; (2):CD007959. DOI:
10.1002/14651858.CD007959.pub3. PMID:
23450581.
![crossref](/image/icon/bnr_ref_cross.gif)
44. Frascio M, Mandolfino F, Imperatore M, Stabilini C, Fornaro R, Gianetta E, et al. The SECCA procedure for faecal incontinence: a
review. Colorectal Dis. 2013; 16(3):167–172. DOI:
10.1111/codi.12403. PMID:
24034552.
![crossref](/image/icon/bnr_ref_cross.gif)
45. Pakravan F, Helmes C. Magnetic anal sphincter augmentation in patients with severe
fecal incontinence. Dis Colon Rectum. 2015; 58(1):109–114. DOI:
10.1097/DCR.0000000000000263. PMID:
25489702.
![crossref](/image/icon/bnr_ref_cross.gif)
46. Wong WD, Congliosi SM, Spencer MP, Corman ML, Tan P, Opelka FG, et al. The safety and efficacy of the artificial bowel sphincter for
fecal incontinence. Dis Colon Rectum. 2002; 45(9):1139–1153. DOI:
10.1007/s10350-004-6381-z. PMID:
12352228.
![crossref](/image/icon/bnr_ref_cross.gif)
47. Trébol J, Carabias-Orgaz A, García-Arranz M, García-Olmo D. Stem cell therapy for faecal incontinence: current state and
future perspectives. World J Stem Cells. 2018; 10(7):82–105. DOI:
10.4252/wjsc.v10.i7.82. PMID:
30079130. PMCID:
PMC6068732.
![crossref](/image/icon/bnr_ref_cross.gif)
48. Forte ML, Andrade KE, Lowry AC, Butler M, Bliss DZ, Kane RL. Systematic review of surgical treatments for fecal
incontinence. Dis Colon Rectum. 2016; 59(5):443–469. DOI:
10.1097/DCR.0000000000000594. PMID:
27050607.
49. Pla-Martí V, Martín-Arévalo J, Martí-Fernández R, Moro-Valdezate D, García-Botello S, Espí-Macías A, et al. Long-term evolution of continence and quality of life after
sphincteroplasty for obstetric fecal incontinence. Ann Coloproctol. 2022; 38(1):13–19. DOI:
10.3393/ac.2020.09.16. PMID:
32972098. PMCID:
PMC8898632.
![crossref](/image/icon/bnr_ref_cross.gif)
50. Kumar S, Medappil N, Singh SK, Chandra A. Complex obstetric perineal injury reconstruction using
antropyloric valve transposition. Ann Coloproctol. 2020; 36(1):58–61. DOI:
10.3393/ac.2018.08.21. PMID:
32146790. PMCID:
PMC7069671.
![crossref](/image/icon/bnr_ref_cross.gif)